Posizioni attive di Reinier Beeuwkes
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Braintree Laboratories, Inc.
 Braintree Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Braintree Laboratories, Inc. manufactures pharmaceutical products and drugs. Its products include SUPREP, NuLYTELY and GoLYTELY. The company was founded by Harry Keegan III and Reinier Beeuwkes in 1982 and is headquartered in Braintree, MA. | Direttore/Membro del Consiglio | 01/01/1982 | - |
| Fondatore | 01/01/1982 | - | |
Ischemix, Inc.
 Ischemix, Inc. Pharmaceuticals: MajorHealth Technology Ischemix, Inc. is a privately-held drug development company based in an undisclosed location. The American company focuses on developing its family of cytoprotective compounds for serious diseases and conditions, with the primary focus being the development of its lead compound, CMX-2043, for the treatment of TBI. Ischemix is working to advance cytoprotective therapies. The company was founded in 1999 by Victor Shashoua, and David DeWahl has been the CEO of the company since 2013. | Direttore/Membro del Consiglio | 01/01/2002 | - |
Storia della carriera di Reinier Beeuwkes
Precedenti posizioni note di Reinier Beeuwkes
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CITIUS PHARMACEUTICALS, INC. | Amministratore Delegato | - | 12/09/2014 |
| Presidente | - | 12/09/2014 |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
Posizioni
| Director/Board Member | 2 |
| Founder | 1 |
| Chief Executive Officer | 1 |
Settori
| Health Technology | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CITIUS PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Braintree Laboratories, Inc.
Braintree Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Braintree Laboratories, Inc. manufactures pharmaceutical products and drugs. Its products include SUPREP, NuLYTELY and GoLYTELY. The company was founded by Harry Keegan III and Reinier Beeuwkes in 1982 and is headquartered in Braintree, MA. | Health Technology |
Ischemix, Inc.
Ischemix, Inc. Pharmaceuticals: MajorHealth Technology Ischemix, Inc. is a privately-held drug development company based in an undisclosed location. The American company focuses on developing its family of cytoprotective compounds for serious diseases and conditions, with the primary focus being the development of its lead compound, CMX-2043, for the treatment of TBI. Ischemix is working to advance cytoprotective therapies. The company was founded in 1999 by Victor Shashoua, and David DeWahl has been the CEO of the company since 2013. | Health Technology |
- Borsa valori
- Insiders
- Reinier Beeuwkes
- Esperienza
